| Product Code: ETC334169 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The mumps vaccine market in the Philippines has been growing as a result of increased healthcare awareness. The CAGR for this market has been approximately 4.1%.
The Philippines mumps vaccine market is primarily driven by vaccination campaigns aimed at preventing mumps outbreaks. Mumps is a contagious viral disease, and vaccination is crucial for maintaining population immunity. Government initiatives, public health awareness, and the need to control vaccine-preventable diseases contribute to the market`s growth.
The Philippines Mumps Vaccine Market could face challenges such as vaccine hesitancy, misinformation, and supply chain disruptions. Ensuring widespread acceptance and accessibility of the vaccine is essential for effective disease prevention.
The disruptions in healthcare services and the focus on COVID-19 vaccinations have impacted routine immunization programs, including those for mumps. The market has faced challenges in terms of reduced vaccination rates.
Key players in the Philippines mumps vaccine market include Merck & Co., Inc., GlaxoSmithKline plc, and Sanofi Pasteur.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Mumps Vaccine Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Mumps Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Mumps Vaccine Market - Industry Life Cycle |
3.4 Philippines Mumps Vaccine Market - Porter's Five Forces |
3.5 Philippines Mumps Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.6 Philippines Mumps Vaccine Market Revenues & Volume Share, By Distribution channel, 2021 & 2031F |
4 Philippines Mumps Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Rising incidence of mumps cases in the Philippines |
4.2.2 Government initiatives to promote vaccination programs |
4.2.3 Increasing awareness about the importance of mumps vaccination among the population |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas |
4.3.2 High costs associated with mumps vaccination |
4.3.3 Concerns about vaccine safety and side effects among the public |
5 Philippines Mumps Vaccine Market Trends |
6 Philippines Mumps Vaccine Market, By Types |
6.1 Philippines Mumps Vaccine Market, By Age Group |
6.1.1 Overview and Analysis |
6.1.2 Philippines Mumps Vaccine Market Revenues & Volume, By Age Group, 2021-2031F |
6.1.3 Philippines Mumps Vaccine Market Revenues & Volume, By Pediatric, 2021-2031F |
6.1.4 Philippines Mumps Vaccine Market Revenues & Volume, By Adult, 2021-2031F |
6.2 Philippines Mumps Vaccine Market, By Distribution channel |
6.2.1 Overview and Analysis |
6.2.2 Philippines Mumps Vaccine Market Revenues & Volume, By Hospitals Pharmacies, 2021-2031F |
6.2.3 Philippines Mumps Vaccine Market Revenues & Volume, By Drug Stores, 2021-2031F |
6.2.4 Philippines Mumps Vaccine Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
7 Philippines Mumps Vaccine Market Import-Export Trade Statistics |
7.1 Philippines Mumps Vaccine Market Export to Major Countries |
7.2 Philippines Mumps Vaccine Market Imports from Major Countries |
8 Philippines Mumps Vaccine Market Key Performance Indicators |
8.1 Percentage increase in mumps vaccination coverage rates |
8.2 Number of government-funded vaccination campaigns conducted |
8.3 Rate of reported mumps cases in the Philippines |
8.4 Number of healthcare facilities offering mumps vaccination services |
8.5 Level of public trust in mumps vaccines and vaccination programs |
9 Philippines Mumps Vaccine Market - Opportunity Assessment |
9.1 Philippines Mumps Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.2 Philippines Mumps Vaccine Market Opportunity Assessment, By Distribution channel, 2021 & 2031F |
10 Philippines Mumps Vaccine Market - Competitive Landscape |
10.1 Philippines Mumps Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Philippines Mumps Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here